2015美国内分泌学会关于肥胖的药物治疗指南解读
摘要
With the improvement of living standards, the incidence of obesity in China is increasing year by year. A series of diseases caused by obesity, such as hypertension, coronary heart disease, diabetes, nonalcoholic fatty liver disease and other diseases, is gradually increasing, which poses serious harm to people's health. Meanwhile, the treatment of obesity has attracted much attention. Diet, exercise and behavior intervention are the main methods of controlling obesity. However, by the influence of various factors, some patients have difficulties to achieve the purpose of reducing weight through the methods mentioned above. The American endocrine society proposes drug treatment of obesity and makes a certain requirement for the standard treatment. It provides a thought for the treatment of obesity due to nonalcoholic fatty liver disease.